Cold Plasma Gas Loaded Microbubbles As A Novel Ultrasound Contrast Agent (Vol 11, Pg 1123, 2019)

Feihong Dong,Jiabin Zhang,Kaile Wang,Zhengxin Liu,Jinsong Guo,Jue Zhang

DOI: https://doi.org/10.1039/c8nr08451c

IF: 6.7

2019-01-01

Nanoscale

Abstract:Correction for 'Cold plasma gas loaded microbubbles as a novel ultrasound contrast agent' by Feihong Dong et al., Nanoscale, 2019, 11, 1123-1130.

What problem does this paper attempt to address?

Correction: Cold plasma gas loaded microbubbles as a novel ultrasound contrast agent

Feihong Dong,Jiabin Zhang,Kaile Wang,Zhengxin Liu,Jinsong Guo,Jue Zhang

DOI: https://doi.org/10.1039/c9nr90091h

IF: 6.7

2019-01-01

Nanoscale

Abstract:Correction for ‘Cold plasma gas loaded microbubbles as a novel ultrasound contrast agent’ by Feihong Dong et al., Nanoscale, 2019, 11, 1123–1130.
Cold Plasma Gas Loaded Microbubbles As a Novel Ultrasound Contrast Agent.

Feihong Dong,Jiabin Zhang,Kaile Wang,Zhengxin Liu,Junming Guo,Jue Zhang

DOI: https://doi.org/10.1039/c8nr08451c

IF: 6.7

2019-01-01

Nanoscale

Abstract:An ultrasound-triggered strategy was developed to achieve the release of free radicals from the plasma microbubbles (PMBs) fabricated by a modified emulsification process.
Correction: Synthetic Ultra-Long Chain Fatty Acyl Based Amphiphilic Lipids As a Dual Function Excipient for the Production of Surfactant-Free Solid Lipid Nanoparticles (Sf-Slns): a Physico-Chemical Study

Wei,Xiaonan Lu,Zegao Wang,Mingdong Dong,Fengqin Feng,Zheng Guo

DOI: https://doi.org/10.1039/c6gc90068b

IF: 9.8

2016-01-01

Green Chemistry

Abstract:Correction for ‘Synthetic ultra-long chain fatty acyl based amphiphilic lipids as a dual function excipient for the production of surfactant-free solid lipid nanoparticles (SF-SLNs): a physico-chemical study’ by Wei Wei et al., Green Chem., 2016, DOI: 10.1039/c6gc00866f.
DNA-loaded Microbubbles with Crosslinked Bovine Serum Albumin Shells for Ultrasound-Promoted Gene Delivery and Transfection

Jianwei Du,Xiao Zhao,Bangbang Li,Yun Mou,Youxiang Wang

DOI: https://doi.org/10.1016/j.colsurfb.2017.10.036

IF: 5.999

2017-01-01

Colloids and Surfaces B Biointerfaces

Abstract:The microbubble is a kind of clinically applied ultrasound contrast agent in disease diagnosis that can also rupture under sonication to increase membrane permeability and promote gene entry into targeted cells. However, the development of ultrasound-mediated gene delivery might be restricted because genes and microbubbles were separated and would not reach the targeted cells simultaneously. Herein, a kind of crosslinked positive microbubbles (CPMBs) were prepared to load DNA as gene vectors to promote gene delivery efficiency. The BSA shell of the CPMBs was crosslinked with disulfide bonds, which obviously enhanced the stability of the CPMBs. Furthermore, the CPMBs revealed sonoporation effects comparable to those of clinically applied SonoVue microbubbles. As DNA and CPMBs were electrostatically linked as an entirety, they would reach cells simultaneously. Thus, with the aid of ultrasound, these DNA-loaded microbubbles promoted DNA entry into cytoplasm more effectively and obtained higher cellular uptake efficiency and better transfection efficiency than DNA-mixed microbubbles. Confocal microscopy results showed that rupturing of the CPMBs/DNA entire microbubbles under sonication could carry DNA directly into the cytoplasm or nucleus. All results indicated that the cytocompatible DNA-loaded microbubbles have promising prospects in ultrasound-mediated gene delivery.
Development of a Polymer Ultrasound Contrast Agent Incorporating Nested Carbon Nanodots

Matthew A. Shirley,Valeria Arango-Aliaga,Ankit Patel,Brian E. Oeffinger,John Eisenbrey,Margaret A. Wheatley

DOI: https://doi.org/10.1177/01617346241279112

IF: 2

2024-09-22

Ultrasonic Imaging

Abstract:Polymer microbubbles have garnered broad interest as potential theranostic agents. However, the capabilities of polymer MBs can be greatly enhanced, particularly regarding the imaging performance and functional versatility of the platform. This study investigates integrating fluorescent carbon nanodots within polylactic acid (PLA) microbubbles. First, the formulations are characterized by their size, microbubble counts, zeta potential, and resonance frequency. Then, the fluorescence capabilities, nanoparticle loading, and acoustic capabilities are examined. Unmodified (U-), carboxylated (C-), and aminated graphene quantum dots (A-GQDs) were separately suspended and synthesized at a 2% w/w ratio with PLA in the organic phase of the water/oil/water double emulsion process. The new microbubbles were characterized using an AccuSizer, Zetasizer, scanning electron microscopy, fluorescence microscopy and fluorimetry, a custom-built acoustic setup, and clinical ultrasound. The GQD microbubbles were sized between 1.4 and 1.9 μm (U = 1.90, C = 1.44, A = 1.72, Unloaded = 2.02 μm). The U-GQD microbubble exhibited a higher bubble concentration/mg PLA ( p < .05) and the A-GQD microbubbles exhibited the greatest shift in zeta potential. Electron microscopy revealed smooth surfaces and a spherical shape, showing that the nanoparticle addition was not deleterious. The A-GQD microbubbles were specifically detectable using DAPI-filtering with fluorescence microscopy and had the highest TRITC-filtered fluorescence. The C-GQD microbubbles had the highest loading efficiency at 59.4% ( p < .05), and the lowest max acoustic enhancement at 5 MHz (U = 19.8, C = 17.6, A = 18.9, Unloaded = 18.5 dB; p < .05). Additionally, all microbubbles were visible and susceptible to inertial cavitation utilizing clinical ultrasound. The A-GQDs showed promise toward improving the theranostic capabilities of the microbubble platform. They have imbued the most advantageous fluorescence capability and slightly improved backscatter enhancement while retaining all the necessary capabilities of an ultrasound contrast agent. Future studies will investigate the coloading potential of A-GQDs and drug within microbubbles.

engineering, biomedical,radiology, nuclear medicine & medical imaging,acoustics
Ultrasound Contrast Agents from Microbubbles to Biogenic Gas Vesicles

Wenlong Zeng,Xiuli Yue,Zhifei Dai

DOI: https://doi.org/10.1515/mr-2022-0020

2022-01-01

Medical Review

Abstract:Microbubbles have been the earliest and most widely used ultrasound contrast agents by virtue of their unique features: such as non-toxicity, intravenous injectability, ability to cross the pulmonary capillary bed, and significant enhancement of echo signals for the duration of the examination, resulting in essential preclinical and clinical applications. The use of microbubbles functionalized with targeting ligands to bind to specific targets in the bloodstream has further enabled ultrasound molecular imaging. Nevertheless, it is very challenging to utilize targeted microbubbles for molecular imaging of extravascular targets due to their size. A series of acoustic nanomaterials have been developed for breaking free from this constraint. Especially, biogenic gas vesicles, gas-filled protein nanostructures from microorganisms, were engineered as the first biomolecular ultrasound contrast agents, opening the door for more direct visualization of cellular and molecular function by ultrasound imaging. The ordered protein shell structure and unique gas filling mechanism of biogenic gas vesicles endow them with excellent stability and attractive acoustic responses. What’s more, their genetic encodability enables them to act as acoustic reporter genes. This article reviews the upgrading progresses of ultrasound contrast agents from microbubbles to biogenic gas vesicles, and the opportunities and challenges for the commercial and clinical translation of the nascent field of biomolecular ultrasound.
The Fabrication of Novel Nanobubble Ultrasound Contrast Agent for Potential Tumor Imaging

Zhanwen Xing,Jinrui Wang,Hengte Ke,Bo Zhao,Xiuli Yue,Zhifei Dai,Jibin Liu

DOI: https://doi.org/10.1088/0957-4484/21/14/145607

IF: 3.5

2010-01-01

Nanotechnology

Abstract:Novel biocompatible nanobubbles were fabricated by ultrasonication of a mixture of Span 60 and polyoxyethylene 40 stearate (PEG40S) followed by differential centrifugation to isolate the relevant subpopulation from the parent suspensions. Particle sizing analysis and optical microscopy inspection indicated that the freshly generated micro/nanobubble suspension was polydisperse and the size distribution was bimodal with large amounts of nanobubbles. To develop a nano-sized contrast agent that is small enough to leak through tumor pores, a fractionation to extract smaller bubbles by variation in the time of centrifugation at 20g (relative centrifuge field, RCF) was suggested. The results showed that the population of nanobubbles with a precisely controlled mean diameter could be sorted from the initial polydisperse suspensions to meet the specified requirements. The isolated bubbles were stable over two weeks under the protection of perfluoropropane gas. The acoustic behavior of the nano-sized contrast agent was evaluated using power Doppler imaging in a normal rabbit model. An excellent power Doppler enhancement was found in vivo renal imaging after intravenous injection of the obtained nanobubbles. Given the broad spectrum of potential clinical applications, the nano-sized contrast agent may provide a versatile adjunct for ultrasonic imaging enhancement and/or treatment of tumors.
Ultrasound-Guided in Vivo Delivery of Cold Plasma Gas for Cancer Therapy Via Microbubbles

Wenyu Guo,Shuo Huang,Jie Dang,Jian An,Feihong Dong,Jue Zhang

DOI: https://doi.org/10.1109/ius52206.2021.9593867

2021-01-01

Abstract:Cold atmospheric plasma (CAP) is expected to be a novel anti-cancer therapy strategy that has much less drug resistance or side effects. However, how to effectively deliver CAP to target lesion in vivo is still challenging. In this paper we design and prepare a kind of stable CAP/C3F8 MBs for image-guided controllable delivery of CAP in vivo, and verify their feasibility for offering a long-time window for CAP-based cancer therapy. The experiment results demonstrate that, CAP/C3F8 MBs cause an effective echogenic response, and the corresponding half-life of signal intensity in vivo achieves over 3 minutes.
Microbubbles for Combination Tumor Treatment (vol 4, 2100050, 2021)

Danqing Huang,Xiaoxuan Zhang,Cheng Zhao,Xiao Fu,Weijing Zhang,Wentao Kong,Bing Zhang,Yuanjin Zhao

DOI: https://doi.org/10.1002/adtp.202100180

IF: 5.003

2021-01-01

Advanced Therapeutics

Abstract:DOI: 10.1002/adtp.202100050 Adv. Therap. 2021, 4, 2100050 The authors are correcting this article because they accidentally included a mistake in figure 4B and figure 6. These errors do not affect the results or conclusions of the paper. The authors sincerely apologize for any confusion this may have caused. In Figure 4b the fluorescent image of green living cell stain was wrongly used during the assembly of Figure 4. The correct figure is as follow: In Figure 6b–6d the X-axis were mislabeled due to a clerical error during the final figure arrangement process. The correct figure is as follow:
Novel ultrasound contrast agent based on microbubbles generated from surfactant mixtures of Span 60 and polyoxyethylene 40 stearate.

Zhanwen Xing,Hengte Ke,Jinrui Wang,Bo Zhao,Xiuli Yue,Zhifei Dai,Jibin Liu

DOI: https://doi.org/10.1016/j.actbio.2010.03.007

IF: 10.633

2010-01-01

Acta Biomaterialia

Abstract:In this study, novel perfluorocarbon-filled microbubbles as ultrasound contrast agent were fabricated using ultrasonication of a surfactant mixture of sorbitan monostearate (Span 60) and polyoxyethylene 40 stearate (PEG40S) in aqueous media. The microbubbles generated from a 1:9 mixture of PEG40S/Span 60 exhibited an average diameter of 2.08±1.27μm. More than 99% of the microbubbles had a mean particle diameter less than 8μm, indicating that they were appropriately sized for intravenous administration as ultrasound contrast agent. The stabilization mechanism of the microbubbles was investigated by the Langmuir–Blodgett technique including the measurements of surface pressure–area (π–A) isotherms and compression–decompression cycles with a two-dimensional monolayer of Span 60 and PEG40S. The dependence on molar fraction of PEG40S in π–A isotherms of mixed monolayers provided a strong evidence of interactions between the two microbubble-forming materials. It is suggested that the monolayer shell imparts good stability to the microbubbles by three means: (1) a low surface tension monolayer hinders dissolution through the reduction of surface tension, which introduces a mechanical surface pressure that counters the Laplace pressure; (2) the presence of a monolayer shell imparts a significant barrier to gas escaping from the core into the aqueous medium; and (3) encapsulation elasticity stabilizes microbubbles against diffusion-driven dissolution and explains the long shelf-life of microbubble contrast agent. The preliminary in vivo ultrasound imaging study showed that such stabilized microbubbles demonstrated excellent enhancement under grey-scale pulse inversion harmonic imaging and power Doppler imaging.
Functional micro/nanobubbles for ultrasound medicine and visualizable guidance

Chen Zhang,Yihong Li,Xinyong Ma,Wenxin He,Chenxi Liu,Zhe Liu

DOI: https://doi.org/10.1007/s11426-020-9945-4

2021-02-25

Science China Chemistry

Abstract:Chemically functionalized gas-filled bubbles with a versatile micro/nano-sized scale have witnessed a long history of developments and emerging applications in disease diagnosis and treatments. In combination with ultrasound and image-guidance, micro/nanobubbles have been endowed with the capabilities of biomedical imaging, drug delivery, gene transfection and disease-oriented therapy. As an external stimulus, ultrasound (US)-mediated targeting treatments have been achieving unprecedented efficiency. Nowadays, US is playing a crucial role in visualizing biological/pathological changes in lives as a reliable imaging technique and a powerful therapeutic tool. This review retrospects the history of ultrasound, the chemistry of functionalized agents and summarizes recent advancements of functional micro/nanobubbles as US contrast agents in preclinical and transclinical research. Latest ultrasound-based treatment modalities in association with functional micro/nanobubbles have been highlighted as their great potentials for disease precision therapy. It is believed that these state-of-the-art micro/nanobubbles will become a booster for ultrasound medicine and visualizable guidance to serve future human healthcare in a more comprehensive and practical manner.

chemistry, multidisciplinary
Freeze-Dried Microfluidic Monodisperse Microbubbles as a New Generation of Ultrasound Contrast Agents

Ugur Soysal,Pedro N Azevedo,Flavien Bureau,Alexandre Aubry,Marcio S Carvalho,Amanda C S N Pessoa,Lucimara G De La Torre,Olivier Couture,Arnaud Tourin,Mathias Fink,Patrick Tabeling

DOI: https://doi.org/10.1016/j.ultrasmedbio.2022.03.011

Abstract:We succeeded in freeze-drying monodisperse microbubbles without degrading their performance, that is, their monodispersity in size and echogenicity. We used microfluidic technology to generate cryoprotected highly monodisperse microbubbles (coefficient of variation [CV] <5%). By using a novel retrieval technique, we were able to freeze-dry the microbubbles and resuspend them without degradation, that is, keeping their size distribution narrow (CV <6%). Acoustic characterization performed in two geometries (a centimetric cell and a millichannel) revealed that the resuspended bubbles conserved the sharpness of the backscattered resonance peak, leading to CVs ranging between 5% and 10%, depending on the geometry. As currently observed with monodisperse bubbles, the peak amplitudes are one order of magnitude higher than those of commercial ultrasound contrast agents. Our work thus solves the question of storage and transportation of highly monodisperse bubbles. This work might open pathways toward novel clinical non-invasive measurements, such as local pressure, impossible to carry out with the existing commercial ultrasound contrast agents.
Corrections to “Microbubble Composition and Preparation for High-Frequency Contrast-Enhanced Ultrasound Imaging: In Vitro and In Vivo Evaluation”

Verya Daeichin,Tom van Rooij,Ilya Skachkov,Bulent Ergin,Patricia A. C. Specht,Alexandre Lima,Can Ince,Johan G. Bosch,Antonius F. W. van der Steen,Nico de Jong,Klazina Kooiman

DOI: https://doi.org/10.1109/tuffc.2021.3067599

2021-06-01

Abstract:In the above article [1], the authors regret that there was a mistake in calculating the mol% of the microbubble coating composition used. For all experiments, the unit in mg/mL was utilized and the conversion mistake only came when converting to mol% in order to define the ratio between the coating formulation components. The correct molecular weight of PEG-40 stearate is 2046.54 g/mol [2], [3], not 328.53 g/mol. On page 556, Table I should read as shown here.
Acoustic Characterization and Enhanced Ultrasound Imaging of Long-Circulating Lipid-Coated Microbubbles.

Hongbo Li,Yanye Yang,Meimei Zhang,Liping Yin,Juan Tu,Xiasheng Guo,Dong Zhang

DOI: https://doi.org/10.1002/jum.14470

2018-01-01

Journal of Ultrasound in Medicine

Abstract:Objectives-A long-circulating lipid-coated ultrasound (US) contrast agent was fabricated to achieve a longer wash-out time and gain more resistance against higher-mechanical index sonication. Systemic physical, acoustic, and in vivo imaging experiments were performed to better understand the underlying mechanism enabling the improvement of contrast agent performance by adjusting the physical and acoustic properties of contrast agent microbubbles. Methods-By simply altering the gas core, a kind of US contrast agent microbubble was synthesized with a similar lipid-coating shell as SonoVue microbubbles (Bracco SpA, Milan, Italy) to achieve a longer wash-out time and higher inertial cavitation threshold. To bridge the structure-performance relationship of the synthesized microbubbles, the imaging performance of the microbubbles was assessed in vivo with SonoVue as a control group. The size distribution and inertial cavitation threshold of the synthesized microbubbles were characterized, and the shell parameters of the microbubbles were determined by acoustic attenuation measurements. All of the measurements were compared with SonoVue microbubbles. Results-The synthesized microbubbles had a spherical shape, a smooth, consistent membrane, and a uniform distribution, with an average diameter of 1.484 m. According to the measured attenuation curve, the synthesized microbubbles resonated at around 2.8 MHz. Although the bubble's shell elasticity (0.20.09 N/m) was comparable with SonoVue, it had relatively greater viscosity and inertial cavitation because of the different gas core. Imaging studies showed that the synthesized microbubbles had a longer circulation time and a better chance of fighting against rapid collapse than SonoVue. Conclusions-Nano/micrometer long-circulating lipid-coated microbubbles could be fabricated by simply altering the core composition of SonoVue microbubbles with a higher-molecular weight gas. The smaller diameter and higher inertial cavitation threshold of the synthesized microbubbles might make it easier to access deep-seated organs and give prolonged imaging enhancement in the liver.
Superparamagnetic nanoparticle-inclusion microbubbles for ultrasound contrast agents

Fang Yang,Ling Li,YiXin Li,Zhongping Chen,Junru Wu,Ning Gu

DOI: https://doi.org/10.1088/0031-9155/53/21/016

IF: 3.5

2008-01-01

Physics in Medicine and Biology

Abstract:We have developed a new type of ultrasound (US) contrast agent, consisting of a gas core, a layer of superparamagnetic iron oxide Fe3O4 nanoparticles (SPIO) and an oil in water outermost layer. The newly developed US contrast agent microbubbles have a mean diameter of 760 nm with a polydisperity index (PI) of 0.699. Our in vitro and in vivo experiments have shown that they have the following advantages compared to gas-encapsulated microbbubbles without SPIO inclusion: (1) they provide better contrast for US images; (2) the SPIO-inclusion microbubbles generate a higher backscattering signal; the mean grey scale is 97.9, which is 38.6 higher than that of microbubbles without SPIO; and ( 3) since SPIO can also serve as a contrast agent of magnetic resonance images (MRI) in vitro, they can be potentially used as contrast agents for double-modality (MRI and US) clinical studies.
Fabrication and Imaging Study of Ultrasound/fluorescence Bi-Modal Contrast Agent Based on Polymeric Microbubbles

XING Zhan-wen,KE Heng-te,WANG Jin-rui,ZHAO Bo,QU En-ze,YUE Xiu-li,DAI Zhi-fei

DOI: https://doi.org/10.3760/cma.j.issn.2095-2848.2013.01.004

2013-01-01

Abstract:Objective To fabricate an ultrasound/fluorescence bi-modal contrast agent by encapsulating fluorescent quantum dots into polymeric ultrasound contrast agent microbubbles.Methods Polylactic acid (PLA,500 mg),(1R)-(+)-camphor (50 mg) and CdSe/ZnS quantum dots (0.5 ml,2.3 μmol/L)were dissolved or dispersed in dichloromethane (10 ml) to form in an organic phase.Ammonium carbonate solution and poly (vinyl alcohol) solution were employed as the internal and external water phase,respectively.The fluorescent microbubbles were generated using double emulsion solvent evaporation and lyophilization methods.The morphology and illumination were characterized by scanning electron microscopy (SEM) and fluorescence spectrophotometry.Synchronized contrast-enhanced ultrasound and fluorescence imaging was acquired by injecting fluorescent microbubbles into the silicone tube coupled to a self-made ultrasound/fluorescence imaging device.Ultrasound/fluorescence bi-modal in vivo imaging was acquired on the kidney of New Zealand rabbits and suckling mice.Results The fluorescent microbubbles were hollow spheres with an averaged diameter of (1.62 ± 1.47) μm.More than 99％ of these microbubbles were less than 8 μm in diameter,which meeted the size criteria for ultrasound contrast agents.The fluorescence emission peak of the microbubbles appeared at 632 nm,indicating that good luminescence properties of quantum dots were maintained.In vitro ultrasound/fluorescence imaging showed no echoic signal when the silicone tube was filled with saline,but there was a strong echo when filled with fluorescent microbubbles.The liquid column with fluorescent microbubbles emitted red luminescence under ultraviolet irradiation.The kidney of the rabbit was remarkably enhanced after the administration of fluorescent microbubbles.Bright fluorescence could be observed at the injection site of the suckling mice via subcutaneous injection.Conclusions A bi-modal but single contrast agent based on polymeric microbubbles has been successfully fabricated for the use of ultrasound and fluorescence imaging.It retains the good characteristics of both echogenicity and fluorescence,which complement each other in case of limitations imposed by uni-modal,single agents.
Fluorinated Copolypeptide‐Stabilized Microbubbles with Maleimide‐Decorated Surfaces As Long‐Term Ultrasound Contrast Agents

Jie Cen,Xianjun Ye,Xiao Liu,Wenhao Pan,Lei Zhang,Guoying Zhang,Nianan He,Aizong Shen,Jinming Hu,Shiyong Liu

DOI: https://doi.org/10.1002/anie.202209610

2022-01-01

Abstract:Gas-filled microbubbles (MBs) have been clinically used as ultrasound (US) contrast agents for disease diagnosis and treatment. However, it remains a great challenge to resolve the dilemma of stability and contrast enhancement of MBs. Herein, amphiphilic copolypeptides bearing fluorinated blocks are synthesized to stabilize perfluorocarbon (PFC)-filled MBs, exhibiting unique stability under both long-term storage and US imaging conditions. The fluorinated inner layer reduces the internal Laplace pressure and greatly improves the stability of MBs, which can be further reinforced by crosslinking of the dipropargyl-containing middle blocks. To overcome the suppressed nonlinear oscillation of polymer shells, maleimide groups are introduced onto the surface of MBs, enabling in situ reaction with plasma proteins to enhance second harmonic signals without compromising the stability of MBs, conferring better US imaging performance than that of Sono Vue (TM) MBs.
The Optimized Fabrication of Nanobubbles as Ultrasound Contrast Agents for Tumor Imaging

Wen Bin Cai,Heng Li Yang,Jian Zhang,Ji Kai Yin,Yi Lin Yang,Li Jun Yuan,Li Zhang,Yun You Duan

DOI: https://doi.org/10.1038/srep13725

IF: 4.6

2015-09-03

Scientific Reports

Abstract:AbstractNanobubbles, which have the potential for ultrasonic targeted imaging and treatment in tumors, have been a research focus in recent years. With the current methods, however, the prepared uniformly sized nanobubbles either undergo post-formulation manipulation, such as centrifugation, after the mixture of microbubbles and nanobubbles, or require the addition of amphiphilic surfactants. These processes influence the nanobubble stability, possibly create material waste and complicate the preparation process. In the present work, we directly prepared uniformly sized nanobubbles by modulating the thickness of a phospholipid film without the purification processes or the addition of amphiphilic surfactants. The fabricated nanobubbles from the optimal phospholipid film thickness exhibited optimal physical characteristics, such as uniform bubble size, good stability and low toxicity. We also evaluated the enhanced imaging ability of the nanobubbles both in vitro and in vivo. The in vivo enhancement intensity in the tumor was stronger than that of SonoVue after injection (UCA; 2 min: 162.47 ± 8.94 dB vs. 132.11 ± 5.16 dB, P < 0.01; 5 min: 128.38.47 ± 5.06 dB vs. 68.24 ± 2.07 dB, P < 0.01). Thus, the optimal phospholipid film thickness can lead to nanobubbles that are effective for tumor imaging.

multidisciplinary sciences
Fabrication of Indocyanine Green and 2H, 3H-Perfluoropentane Loaded Microbubbles for Fluorescence and Ultrasound Imaging

Yutong He,Qiang Wu,Rong Ma,Shufang Chang,Pengfei Shao,Ronald Xu

DOI: https://doi.org/10.1117/12.2211333

2016-01-01

Abstract:As a near-infrared (NIR) fluorescence dye, Indocyanine Green (ICG) has not gained broader clinical applications, owing to its multiple limitations such as concentration-dependent aggregation, low fluorescence quantum yield, poor physicochemical stability and rapid elimination from the body. In the meanwhile, 2H,3H-perfluoropentane (H-PFP) has been widely studied in ultrasound imaging as a vehicle for targeted delivery of contrast agents and drugs. We synthesized a novel dual-modal fluorescence and ultrasound contrast agent by encapsulating ICG and H-PFP in lipid microbubbles using a liquid-driven coaxial flow focusing (LDCFF) process. Uniform microbubbles with the sizes ranging from 1-10um and great ICG loading efficiency was achieved by this method. Our benchtop experiments showed that ICG/H-PFP microbubbles exhibited less aggregation, increased fluorescence intensity and more stable photostability compared to free ICG aqueous solution. Our phantom experiments demonstrated that ICG/H-PFP microbubbles enhanced the imaging contrasts in fluorescence imaging and ultrasonography. Our animal experiments indicated that ICG/H-PFP microbubbles extended the ICG life time and facilitated dual mode fluorescence and ultrasound imaging in vivo.
Corrigendum for “Intravital microscopy of localized stem cell delivery using microbubbles and acoustic radiation force” (Vol. 112, Issue 1, pp. 220–227)

Tom J. A. Kokhuis,Ilya Skachkov,Benno A. Naaijkens,Lynda J. M. Juffermans,Otto Kamp,Klazina Kooiman,Antonius F. W. Steen,Michel Versluis,Nico Jong

DOI: https://doi.org/10.1002/bit.27727

IF: 3.8

2021-05-20

Biotechnology and Bioengineering

Abstract:The authors regret that there was a mistake in calculating the mol% of the microbubble coating composition used. For all experiments the unit in mg/ml was utilized and the conversion mistake only came when converting to mol% to define the ratio between the coating formulation components. The correct molecular weight of PEG-40 stearate is 2046.54 g/mol (Kilic & Bolukcu, <a class="bibLink tab-link" href="#bit27727-bib-0001">2018</a>; Shen et al., <a class="bibLink tab-link" href="#bit27727-bib-0002">2008</a>), not 328.53 g/mol. On page 221, it should read "The coating was composed of DSPC (84.8 mol%; Sigma-Aldrich), PEG-40 stearate (8.2 mol%; Sigma-Aldrich), DSPE-PEG(2000) (5.9 mol%; Avanti Polar Lipids) and DSPE-PEG(2000)-biotin (1.1 mol%; Avanti Polar Lipids)." This correction does not change the conclusions published in this study.

biotechnology & applied microbiology

Cold Plasma Gas Loaded Microbubbles As A Novel Ultrasound Contrast Agent (Vol 11, Pg 1123, 2019)

Correction: Cold plasma gas loaded microbubbles as a novel ultrasound contrast agent

Cold Plasma Gas Loaded Microbubbles As a Novel Ultrasound Contrast Agent.

Correction: Synthetic Ultra-Long Chain Fatty Acyl Based Amphiphilic Lipids As a Dual Function Excipient for the Production of Surfactant-Free Solid Lipid Nanoparticles (Sf-Slns): a Physico-Chemical Study

DNA-loaded Microbubbles with Crosslinked Bovine Serum Albumin Shells for Ultrasound-Promoted Gene Delivery and Transfection

Development of a Polymer Ultrasound Contrast Agent Incorporating Nested Carbon Nanodots

Ultrasound Contrast Agents from Microbubbles to Biogenic Gas Vesicles

The Fabrication of Novel Nanobubble Ultrasound Contrast Agent for Potential Tumor Imaging

Ultrasound-Guided in Vivo Delivery of Cold Plasma Gas for Cancer Therapy Via Microbubbles

Microbubbles for Combination Tumor Treatment (vol 4, 2100050, 2021)

Novel ultrasound contrast agent based on microbubbles generated from surfactant mixtures of Span 60 and polyoxyethylene 40 stearate.

Functional micro/nanobubbles for ultrasound medicine and visualizable guidance

Freeze-Dried Microfluidic Monodisperse Microbubbles as a New Generation of Ultrasound Contrast Agents

Corrections to “Microbubble Composition and Preparation for High-Frequency Contrast-Enhanced Ultrasound Imaging: In Vitro and In Vivo Evaluation”

Acoustic Characterization and Enhanced Ultrasound Imaging of Long-Circulating Lipid-Coated Microbubbles.

Superparamagnetic nanoparticle-inclusion microbubbles for ultrasound contrast agents

Fabrication and Imaging Study of Ultrasound/fluorescence Bi-Modal Contrast Agent Based on Polymeric Microbubbles

Fluorinated Copolypeptide‐Stabilized Microbubbles with Maleimide‐Decorated Surfaces As Long‐Term Ultrasound Contrast Agents

The Optimized Fabrication of Nanobubbles as Ultrasound Contrast Agents for Tumor Imaging

Fabrication of Indocyanine Green and 2H, 3H-Perfluoropentane Loaded Microbubbles for Fluorescence and Ultrasound Imaging

Corrigendum for “Intravital microscopy of localized stem cell delivery using microbubbles and acoustic radiation force” (Vol. 112, Issue 1, pp. 220–227)